Where to Get a Mounjaro Pen Prescription & Refill in Bangkok, Thailand
Table of contents
- Obesity and Diabetes – Why Is Management Important?
- Mounjaro for Weight Loss in Thailand
- Mounjaro for Diabetes Treatment in Thailand
- Mounjaro vs. Other Medications – How Does It Compare?
- How Much Does Mounjaro Cost in Bangkok?
- The Science Behind Mounjaro – How It Works
- Real Mounjaro Patient Results: Before-and-After Body Composition Analysis
- Getting Mounjaro in Thailand – Prescription & Availability
- How to Get Mounjaro in Thailand?
- How Can You Tell If Your Mounjaro in Thailand Is Genuine?
- Frequently Asked Questions About Getting Mounjaro Prescription in Bangkok, Thailand
Actual Mounjaro® KwikPen dispensed at H.U.M. Clinic, Bangkok,
sourced through authorized pharmaceutical distributors in Thailand
sourced through authorized pharmaceutical distributors in Thailand
(Glucagon-Like Peptide-1) receptors. It is the first dual-acting incretin therapy approved for Type 2 diabetes and weight loss. With its superior efficacy in lowering blood sugar and promoting significant fat reduction, Mounjaro is revolutionizing diabetes and obesity treatment worldwide.
How Does Mounjaro Work for Diabetes & Weight Loss?
Mounjaro enhances insulin secretion, reduces appetite, and improves metabolic function. Studies show that it outperforms GLP-1-only drugs like Ozempic and Wegovy, leading to greater HbA1c reduction and more substantial weight loss.
Availability of Mounjaro in Thailand
Mounjaro is officially available in Thailand through licensed doctors, hospitals, and clinics. The currently available doses include Mounjaro 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg pens, each designed as a multi-dose injector suitable for four weekly doses. Patients seeking to buy Mounjaro pens in Bangkok must consult a licensed medical professional to obtain a valid prescription and ensure proper medical supervision.
Obesity and Diabetes – Why Is Management Important?
Obesity and diabetes have reached epidemic levels globally, posing serious health risks. In 2022, 1 in 8 people worldwide were living with obesity, and rates have more than doubled since 1990. Thailand is no exception, with rising cases of Type 2 diabetes and metabolic disorders. These conditions significantly increase the risk of heart disease, stroke, and certain cancers, indicating an urgent need for effective medical interventions.
Why Traditional Weight Loss Methods Often Fail
Many individuals struggle with long-term weight management despite diet and exercise. Hormonal imbalances, insulin resistance, and metabolic dysfunction make it difficult for the body to regulate fat storage and energy use, leading to weight regain.
How Mounjaro Addresses Obesity & Diabetes
Mounjaro (Tirzepatide) targets both GIP and GLP-1 receptors, improving insulin sensitivity, appetite control, and fat metabolism. This dual-action therapy provides sustainable weight loss and blood sugar control, offering hope for patients who have struggled with traditional approaches.
Mounjaro for Weight Loss in Thailand
Mounjaro (Tirzepatide) is revolutionizing weight loss treatment with its unique dual GIP and GLP-1 receptor activation, providing more effective fat reduction and appetite control than traditional medications. By enhancing metabolism and reducing cravings, Mounjaro helps patients achieve significant, sustainable weight loss.
How Effective is Mounjaro for Weight Loss?
According to the clinical studies on weight loss, the SURMOUNT-1 clinical trial, published in The New England Journal of Medicine (NEJM), found that patients taking 15mg of Mounjaro lost up to 22.5% of their body weight over 72 weeks. These results make Mounjaro one of the most effective weight loss medications, surpassing GLP-1-only treatments like Ozempic, Saxenda, and Wegovy.
Table 1: Clinical Study Comparison – Mounjaro vs. other GLP-1 medication for Weight Loss
| Medication | Average Weight Loss (%) | Clinical Trial Reference |
|---|---|---|
| Mounjaro (Tirzepatide) | Up to 22.5% | SURMOUNT-1 (NEJM, 2022) |
| Wegovy (Semaglutide) | 15-17% | STEP Trials (NEJM, 2021) |
| Ozempic (Semaglutide) | 10-15% | SUSTAIN Trials (Lancet, 2018) |
Mounjaro for Diabetes Treatment in Thailand
Mounjaro (Tirzepatide) offers a breakthrough solution for Type 2 diabetes management by combining GIP and GLP-1 receptor activation to enhance blood sugar control and insulin sensitivity. Clinical trials show its superior efficacy in lowering HbA1c levels compared to traditional diabetes medications. Approved in Thailand in 2024, Mounjaro is now available, providing a powerful option for patients looking to improve diabetic control and overall metabolic health in Bangkok, Thailand.
How Effective is Mounjaro for Diabetes?
According to clinical Trials on HbA1c Reduction & Insulin Sensitivity, The SURPASS-2 clinical trial, published in NEJM, compared Mounjaro vs. Ozempic (Semaglutide) in diabetes management. It found that:
- 📊 Mounjaro 15mg reduced HbA1c by 2.3%, compared to 1.86% with Semaglutide 1mg over 40 weeks.
- 📉 Patients experienced significant fasting blood sugar reductions, improving overall glycemic control.
Table 2: Clinical Study Comparison – Mounjaro vs. Other Diabetes Treatments
| Medication | Average HbA1c Reduction (%) | Clinical Trial Reference |
|---|---|---|
| Mounjaro (Tirzepatide) 15mg | 2.3% | SURPASS-2 (NEJM, 2021) |
| Semaglutide (Ozempic) 1mg | 1.86% | SUSTAIN Trials (Lancet, 2018) |
| Insulin Degludec (Tresiba) | 1.94% | BEGIN Trials (Diabetes Care, 2012) |
Mounjaro vs. Other Medications – How Does It Compare?
Mounjaro (Tirzepatide) is a first-in-class medication that activates both GIP and GLP-1 receptors, making it more effective than traditional GLP-1-only treatments. This section explores how Mounjaro compares to Zepbound (another Tirzepatide-based medication) and GLP-1 medications, like Ozempic and Wegovy, in Bangkok.
Mounjaro vs. Zepbound – What’s the Difference?
Although both contain Tirzepatide, they are marketed under different names depending on the country. In some regions, Zepbound is branded for weight loss, while Mounjaro is designated for diabetes treatment.
In Thailand, however, Mounjaro is officially approved for both Type 2 diabetes and weight loss, making it a versatile treatment option for patients managing obesity or diabetic conditions.
In Thailand, however, Mounjaro is officially approved for both Type 2 diabetes and weight loss, making it a versatile treatment option for patients managing obesity or diabetic conditions.
- Mounjaro – FDA-approved for Type 2 diabetes and also indicated for weight loss in Thailand.
- Zepbound – FDA-approved exclusively for obesity and weight loss in selected markets outside Thailand.
Mounjaro vs. GLP-1-Only Medications
Why Mounjaro is More Effective Than Ozempic & Wegovy
Mounjaro’s dual-incretin mechanism gives it an advantage over Semaglutide-based medications, providing stronger metabolic and fat-loss benefits. Mounjaro activates both:
- GIP (Glucose-dependent insulinotropic polypeptide) – Enhances insulin release and improves fat metabolism.
- GLP-1 (Glucagon-like peptide-1) – Regulates appetite, slows digestion, and lowers blood sugar.
Key Differences in Weight Loss & Blood Sugar Control
- Mounjaro (Tirzepatide 15mg) – Up to 22.5% weight loss and 2.3% HbA1c reduction.
- Wegovy (Semaglutide 2.4mg) – Up to 16% weight loss and 1.86% HbA1c reduction.
- Ozempic (Semaglutide 1mg) – Moderate weight loss and diabetes management.
How Much Does Mounjaro Cost in Bangkok?
At H.U.M. Clinic, Mounjaro (tirzepatide) is priced by dose, starting at 13,900 THB for the 2.5 mg dose and increasing with higher doses up to 15 mg. A doctor consultation is 1,500 THB per visit. For the full dose-by-dose Mounjaro price list, see our Mounjaro pen price and packages in Bangkok.
The Science Behind Mounjaro – How It Works
Mounjaro (Tirzepatide) is the first dual-incretin medication that activates both GIP and GLP-1 receptors, making it more effective for weight loss and diabetes management than traditional GLP-1-only treatments like Ozempic. This section breaks down how Mounjaro works at a biological level, explaining its impact on metabolism, insulin sensitivity, and appetite regulation.
Understanding GIP & GLP-1 Mechanisms
GLP-1 Receptor Activation (Like Ozempic & Wegovy)
- Stimulates insulin release after meals.
- Suppresses glucagon secretion, lowering blood sugar.
- Delays gastric emptying, leading to prolonged fullness.
- Reduces appetite, supporting weight loss.
GIP Receptor Activation (Unique to Mounjaro)
- Improves insulin sensitivity in muscle, liver, and fat cells.
- Enhances fat metabolism, reducing fat accumulation.
- Further suppresses appetite, leading to greater weight loss.
- Synergizes with GLP-1, making Mounjaro more effective.
Clinical Trials Supporting Mounjaro’s Effectiveness
Large-scale studies, including SURPASS-1 to SURPASS-5, published in The Lancet and The New England Journal of Medicine (NEJM), found that Mounjaro:
- 📊 Reduced HbA1c by up to 2.3% (vs. 1.86% with Semaglutide).
- 📉 Led to 22.5% weight loss in obese patients (vs. 15% with Semaglutide).
- 🔬 Improved insulin sensitivity, lowering fasting blood sugar significantly.
Real Mounjaro Patient Results: Before-and-After Body Composition Analysis
All body composition measurements were performed at H.U.M. Clinic using the InBody 380 under routine clinical follow-up. Outcomes vary between individuals and should not be considered typical or guaranteed. Factors such as baseline body composition, metabolic health, adherence to treatment, diet, exercise, sleep, and other medical conditions can influence results.
Patients are monitored regularly by our physicians, with body composition reassessed throughout treatment. Medication dosing, nutritional guidance, and exercise recommendations are individualized and adjusted according to each patient’s response, helping support fat loss while preserving lean body mass whenever possible.
Patients are monitored regularly by our physicians, with body composition reassessed throughout treatment. Medication dosing, nutritional guidance, and exercise recommendations are individualized and adjusted according to each patient’s response, helping support fat loss while preserving lean body mass whenever possible.
| Patient | Duration | Dose | Weight | Body Fat Mass | Skeletal Muscle | Visceral Fat |
|---|---|---|---|---|---|---|
| 32-yr Male | 6 months | 2.5 mg → 5 mg | 94.4 → 77.0 kg (-18.4%) | 23.1 → 5.3 kg (-77.1%) | 41.1 → 41.4 kg (+0.7%) | 10 → 1 (-90.0%) |
| 54-yr Male | 7 weeks | 2.5 mg → 5 mg | 103.1 → 94.9 kg (-7.9%) | 27.2 → 18.2 kg (-33%) | 43.2 → 43.3 kg (+0.1 kg) | 12 → 8 (-33.3%) |
| 47-yr Male | 9 months | 2.5 mg → 5 mg → 7.5 mg → 10 mg | 95.8 → 84.3 kg (-12.0%) | 18.9 → 10.5 kg (-44.4%) | 44.2 → 42.1 kg (-4.8%) | 7 → 4 (-42.9%) |
| 40-yr Female | 4 months | 2.5 mg → 5 mg → 7.5 mg | 65.8 → 55.9 kg (-15.0%) | 26.1 → 18.5 kg (-29.1%) | 21.8 → 20.2 kg (-7.3%) | 13 → 8 (-38.5%) |
Case 1: 32-Year-Old Male, 6 Months
This patient came to us at 94.4 kg and, over six months on Mounjaro at 2.5 mg then 5 mg, reached 77.0 kg, a loss of 17.4 kg (18.4%). Almost all of that loss came from fat: his body fat mass fell from 23.1 kg to 5.3 kg, and his percent body fat dropped from 24.5% to 6.9%. What we look for most is that muscle is kept, and his skeletal muscle actually held and rose slightly from 41.1 kg to 41.4 kg. His visceral fat, the fat stored around the internal organs, came down from a level of 10 to 1, which matters a great deal for long-term heart and metabolic health.
Case 2: 54-Year-Old Male, 7 Weeks
In only seven weeks on Mounjaro at 2.5 mg then 5 mg, this patient reduced his body fat mass from 27.2 kg to 18.2 kg, a drop of about 33%. His weight moved from 103.1 kg to 94.9 kg over the same period, a 7.9% reduction. Just as important, his muscle stayed intact, holding from 43.2 kg to 43.3 kg, so the early change was fat coming off rather than muscle. His visceral fat level also improved quickly, from 12 to 8 (a 33.3% reduction), which is an encouraging sign this early in treatment.
Case 3: 47-Year-Old Male, 9 Months
Over nine months, with his dose adjusted in steps from 2.5 mg up to 10 mg, this patient lowered his body fat mass from 18.9 kg to 10.5 kg, a loss of 8.4 kg (44.4%), and his percent body fat fell from 19.7% to 12.4%. His weight came down from 95.8 kg to 84.3 kg, a 12.0% reduction. His skeletal muscle changed only slightly, from 44.2 kg to 42.1 kg, a small shift compared with the amount of fat he lost. His visceral fat improved from a level of 7 to 4, a 42.9% reduction.
Case 4: 40-Year-Old Female, 4 Months
Over four months, with her dose stepped from 2.5 mg up to 7.5 mg, this patient reduced her body fat mass from 26.1 kg to 18.5 kg, a loss of 7.6 kg (29.1%), and her percent body fat moved from 39.7% to 33.0%. Her weight came down from 65.8 kg to 55.9 kg, a 15.0% reduction. Her skeletal muscle shifted modestly from 21.8 kg to 20.2 kg. Her visceral fat level dropped from 13 to 8, a 38.5% reduction.
All body composition measurements were performed at H.U.M. Clinic using the InBody 380 under routine clinical follow-up. Outcomes vary between individuals and should not be considered typical or guaranteed. Factors such as baseline body composition, metabolic health, adherence to treatment, diet, exercise, sleep, and other medical conditions can influence results.
Patients are monitored regularly by our physicians, with body composition reassessed throughout treatment. Medication dosing, nutritional guidance, and exercise recommendations are individualized and adjusted according to each patient’s response, helping support fat loss while preserving lean body mass whenever possible.
Patients are monitored regularly by our physicians, with body composition reassessed throughout treatment. Medication dosing, nutritional guidance, and exercise recommendations are individualized and adjusted according to each patient’s response, helping support fat loss while preserving lean body mass whenever possible.
Getting Mounjaro in Thailand – Prescription & Availability
For those looking to buy Mounjaro (Tirzepatide) pen in Bangkok, patients must consult a licensed doctor before purchasing this prescription-only medication. Whether you’re starting treatment or refilling a prescription, it’s essential to follow safe and legal channels to ensure medication authenticity and proper medical supervision.
How to Get a Mounjaro Prescription in Thailand
To buy Mounjaro (Tirzepatide) pen at our Bangkok clinic at a competitive price, follow these steps:
- Contact us
via LINE, WhatsApp, or email to schedule an appointment or place an order.
- Doctor Consultation
Our licensed physician will evaluate your health and determine if Mounjaro is suitable.
- Medical Eligibility Check
Conditions such as Type 2 diabetes, obesity, and metabolic disorders are assessed.
- Blood Work (if required)
Some patients may need baseline lab tests before starting treatment.
- Prescription Approval
A qualified healthcare provider issues the prescription.
- Patient Education
Guidance on dosage, injection technique, and expected results.
Refill Mounjaro Prescription & Online Purchase Guidelines
If you’re already on Mounjaro therapy, you can refill your prescription at H.U.M. Clinic Bangkok with:
- Doctor consultations for new and existing users.
- Hassle-free prescription refills with medical oversight.
- Temperature-controlled storage & delivery (2-8°C) to maintain medication stability.
How to Get Mounjaro in Thailand?
Mounjaro (Tirzepatide) is available only through licensed clinics and hospitals that source directly from Thailand’s official pharmaceutical distributor, Zuellig Pharma, under authorization from Eli Lilly, the original manufacturer. This ensures patients receive authentic, properly stored medication with full medical supervision. For those in Bangkok seeking a reliable provider to buy Mounjaro, H.U.M. Clinic offers Mounjaro for weight loss and diabetes treatment with expert consultation and personalized care.
H.U.M. Clinic, a leading weight loss clinic in Bangkok provides safe and legal access to Mounjaro for patients in Thailand. During your consultation, our expert doctors will:
- Assess your health profile to determine suitability.
- Discuss Mounjaro’s benefits, dosage, and potential side effects.
- Develop a personalized plan for weight loss or diabetes management.
Why Choose H.U.M. Clinic Bangkok for Your Mounjaro Refill?
- Licensed medical clinic with pharmaceutical-grade Mounjaro.
- Proper storage & handling in temperature-controlled conditions (2-8°C).
- Comprehensive weight loss & diabetes programs, including IV therapy, peptide therapy, and hormone balancing.
- Convenient Bangkok location (Asok area at Asoke Intersection).
How Can You Tell If Your Mounjaro in Thailand Is Genuine?
One of the most common questions our doctors hear from patients is a simple but important one: how do you know the Mounjaro you are giving me is real? At H.U.M. Clinic, every Mounjaro KwikPen we dispense comes directly from Zuellig Pharma, the official authorized distributor of Mounjaro in Thailand. This means the medication you receive has moved through a single regulated supply chain from the manufacturer to our clinic, with no third-party resellers along the way.
Official Verification From Zuellig Pharma
Upon our request, Zuellig Pharma provided written confirmation that H.U.M. Clinic purchases authentic Mounjaro KwikPen products directly through the authorized supply chain in Thailand.
The verification confirms that H.U.M. Clinic sources Mounjaro directly from Zuellig Pharma, the official distributor, with documented purchase records.
Frequently Asked Questions About Getting Mounjaro Prescription in Bangkok, Thailand
Can I travel to Thailand and get a Mounjaro prescription as a foreigner?
Yes, foreign patients can buy Mounjaro in Bangkok, Thailand, after receiving a consultation and prescription from a licensed doctor. H.U.M. Clinic provides medical evaluations and prescriptions for both residents and medical tourists seeking weight loss or diabetes treatment.
How much does Mounjaro cost in Bangkok?
At H.U.M. Clinic, Mounjaro starts at 13,900 THB and the price depends on your prescribed dose. A doctor consultation is 1,500 THB per visit. You can check the current dose-by-dose Mounjaro prices on our weight-loss pen price page.
How do I transition from another GLP-1 medication (Ozempic, Wegovy) to Mounjaro?
Switching from Semaglutide-based medications (Ozempic, Wegovy) to Mounjaro requires a medical consultation. Doctors will adjust your dosage to minimize side effects and ensure a smooth transition based on your current medication, health status, and treatment goals.
Does Mounjaro need to be refrigerated during travel in Thailand?
Yes, Mounjaro must be stored between 2-8°C (35-46°F) to maintain effectiveness. When traveling, use an insulated medical-grade travel cooler. Licensed clinics like H.U.M. Clinic ensure proper cold-chain storage and provide temperature-controlled home delivery.
How many Mounjaro (Tirzepatide) pens should I buy in Bangkok?
Mounjaro is a once-weekly injection, and prescriptions are typically issued monthly. However, follow-up visits depend on your treatment plan, dosage adjustments, and lab test results. Some clinics, like H.U.M. Clinic, offer remote prescription refills after an initial consultation.
Can I use Mounjaro if I have pre-existing medical conditions?
A doctor will assess your medical history, blood tests, and potential risks before prescribing Mounjaro. It depends on the condition. Mounjaro may not be suitable for individuals with:
- A personal or family history of medullary thyroid carcinoma (MTC)
- Multiple endocrine neoplasia syndrome type 2 (MEN 2)
- Severe gastrointestinal disorders (such as gastroparesis)
Is Zepbound available in Bangkok, Thailand?
The active ingredient in Zepbound, Tirzepatide, is available in Thailand, largely marketed under the brand name Mounjaro. While those specifically branded as Zepbound for weight loss might not be widely stocked, Mounjaro is available for weight management at specialized clinics and pharmacies in Bangkok and other major areas, requiring a prescription.
How does Mounjaro work for weight loss patients?
Mounjaro (tirzepatide) works for weight loss by mimicking two natural gut hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which together suppress appetite, increase feelings of fullness, and slow gastric emptying. As a dual-agonist medication, it acts on brain receptors to reduce hunger to support a sustainable calorie deficit.
Wichakorn Jitpraphun, M.D. (Dr. Kamin) is the Co-founder and Medical Director of H.U.M. Clinic, Bangkok. A physician licensed by the Medical Council of Thailand (License No. 51754), he has over 10 years of clinical experience, practicing since 2016. Dr. Kamin holds Certificate Diplomas in Sexual Medicine and Sexology from Thammasat University and Andrology certification from the Society of Men’s Health Singapore. His clinical practice focuses on testosterone replacement therapy (TRT), Men’s health, sexual medicine, HIV prevention and treatment, peptide therapy, and evidence-based medical weight management.